Sartorius Aktiengesellschaft

SWX:SRT3 Stock Report

Market Cap: CHF 13.1b

Sartorius Valuation

Is SRT3 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of SRT3 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: SRT3 (CHF212.8) is trading below our estimate of future cash flow value (CHF312.2)

Significantly Below Future Cash Flow Value: SRT3 is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SRT3?

Key metric: As SRT3 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SRT3. This is calculated by dividing SRT3's market cap by their current earnings.
What is SRT3's PE Ratio?
PE Ratio103.4x
Earnings€154.90m
Market Cap€14.43b

Price to Earnings Ratio vs Peers

How does SRT3's PE Ratio compare to its peers?

The above table shows the PE ratio for SRT3 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average30.2x
LONN Lonza Group
40.6x17.27%CHF 36.4b
BANB Bachem Holding
32.7x17.00%CHF 4.3b
SFZN Siegfried Holding
21.4x9.93%CHF 3.6b
TECN Tecan Group
26.3x13.11%CHF 1.6b
SRT3 Sartorius
100.9x21.65%CHF 14.0b

Price-To-Earnings vs Peers: SRT3 is expensive based on its Price-To-Earnings Ratio (100.9x) compared to the peer average (29.9x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does SRT3's PE Ratio compare vs other companies in the European Life Sciences Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
SRT3 103.4xIndustry Avg. 34.2xNo. of Companies3PE01632486480+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: SRT3 is expensive based on its Price-To-Earnings Ratio (100.9x) compared to the Global Life Sciences industry average (34.2x).

Price to Earnings Ratio vs Fair Ratio

What is SRT3's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SRT3 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio103.4x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SRT3's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SRT3 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 212.80
CHF 241.82
+13.64%
12.39%CHF 276.84CHF 166.10n/a19
Feb ’27n/a
CHF 245.35
0%
12.25%CHF 279.61CHF 160.43n/a19
Jan ’27n/a
CHF 246.41
0%
12.33%CHF 284.96CHF 163.50n/a19
Dec ’26n/a
CHF 243.57
0%
12.00%CHF 284.29CHF 163.11n/a19
Nov ’26n/a
CHF 240.05
0%
11.96%CHF 282.03CHF 161.82n/a20
Oct ’26n/a
CHF 239.00
0%
12.07%CHF 289.92CHF 163.66n/a20
Sep ’26n/a
CHF 244.76
0%
12.20%CHF 292.33CHF 165.03n/a20
Aug ’26n/a
CHF 238.59
0%
12.82%CHF 287.51CHF 162.30n/a20
Jul ’26n/a
CHF 243.07
0%
12.88%CHF 289.60CHF 170.02n/a20
Jun ’26n/a
CHF 247.20
0%
13.08%CHF 298.90CHF 170.00n/a20
May ’26n/a
CHF 252.67
0%
12.85%CHF 299.72CHF 170.47n/a21
Apr ’26n/a
CHF 271.96
0%
11.97%CHF 324.22CHF 173.55n/a21
Mar ’26n/a
CHF 270.27
0%
12.06%CHF 318.80CHF 170.65CHF 212.8020
Feb ’26n/a
CHF 260.65
0%
13.35%CHF 312.27CHF 172.22n/a20
Jan ’26n/a
CHF 245.48
0%
13.26%CHF 297.95CHF 161.08n/a20
Dec ’25n/a
CHF 248.61
0%
13.10%CHF 299.20CHF 161.76n/a19
Nov ’25n/a
CHF 248.80
0%
13.45%CHF 299.37CHF 161.85n/a18
Oct ’25n/a
CHF 246.61
0%
14.90%CHF 299.75CHF 162.05n/a18
Sep ’25n/a
CHF 249.84
0%
15.95%CHF 314.79CHF 162.56n/a17
Aug ’25n/a
CHF 255.98
0%
17.76%CHF 353.52CHF 163.09n/a17
Jul ’25n/a
CHF 303.01
0%
13.87%CHF 365.68CHF 202.09n/a16
Jun ’25n/a
CHF 311.86
0%
13.11%CHF 371.93CHF 205.54n/a16
May ’25n/a
CHF 324.79
0%
11.74%CHF 393.09CHF 235.85n/a16
Apr ’25n/a
CHF 340.26
0%
11.93%CHF 403.74CHF 233.49n/a16
Mar ’25n/a
CHF 318.97
0%
12.84%CHF 371.41CHF 228.56n/a16
CHF 251.02
Fair Value
15.2% undervalued intrinsic discount
19
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/04 21:21
End of Day Share Price 2026/03/04 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sartorius Aktiengesellschaft is covered by 37 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Charles PitmanBarclays
Charles PitmanBarclays
Samuel EnglandBerenberg